Lucas Oliveira Maia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lucas Oliveira Maia has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Ana Cláudia Mesquita Garcia
Federal University of Alfenas
9 shared publications - Dimitri Daldegan-Bueno
School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand
9 shared publications - Draulio Barros de Araujo
Federal University of Rio Grande do Norte
5 shared publications - Isabel Wießner
Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil
5 shared publications - Luís Fernando Tófoli
Laboratory for Interdisciplinary Studies on Psychoactive Substances (LEIPSI) , State University of Campinas, Campinas, Brazil
5 shared publications - Everson Meireles
Federal University of Alfenas
4 shared publications
Latest Publications
- 19 May 2026
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- p. 1-11
Integration of the Psychedelic Experience Among Brazilians: A Survey Study
Psychedelic substances are increasingly studied for their potential contributions to mental health care, particularly due to their capacity to promote profound emotional, cognitive, and behavioral ...
- 19 May 2026
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- p. 1-11
Integration of the Psychedelic Experience Among Brazilians: A Survey Study
Psychedelic substances are increasingly studied for their potential contributions to mental health care, particularly due to their capacity to promote profound emotional, cognitive, and behavioral ...
- Open Access
- 31 March 2026
- Published by Springer Nature in Journal of Religion and Health
- Vol. 65 (4) , 3699-3715
The Brazilian Version of the Mystical Orientation Scale Revised (MOSR-BR): An Exploratory Study
Mystical experiences are commonly described in the context of psychedelic use and other forms of expanded states of consciousness. Although the Mystical Orientation Scale Revised (MOSR) has been used in international studies, no Brazilian Portuguese version had been tested to date. This exploratory study aimed to translate, culturally adapt, and examine the psychometric properties of the MOSR for the Brazilian population (MOSR-BR). The process followed international guidelines, including translation, back-translation, expert committee review, and pre-testing. The final version was applied to a sample of 505 Brazilian adults. Exploratory factor analysis supported a unidimensional structure, explaining 47.6% of the variance. The MOSR-BR showed high internal consistency (α = .95), slightly higher than the original and Italian versions. Construct validity was evidenced by significant positive correlations between MOSR-BR and all subscales of the Death Transcendence Scale, as well as with the Religious and Existential Well-Being subscales of the Spiritual Well-Being Scale. The scale also discriminated between psychedelic substance users and non-users, with higher mystical orientation scores among occasional and frequent users. This exploratory study provides preliminary evidence supporting the value of further research on the MOSR-BR to address acknowledged limitations with the pilot study, including the cross-sectional design, non-causal inferences, recruitment method and participant self-selection, limited generalizability, absence of confirmatory factor analysis and test–retest reliability, and the need for larger and more diverse samples with longitudinal reliability assessment.
- 31 March 2026
- Published by Springer Nature in Journal of Religion and Health
- Vol. 65 (4) , 3699-3715
Open AccessThe Brazilian Version of the Mystical Orientation Scale Revised (MOSR-BR): An Exploratory Study
Mystical experiences are commonly described in the context of psychedelic use and other forms of expanded states of consciousness. Although the Mystical Orientation Scale Revised (MOSR) has been used in international studies, no Brazilian Portuguese version had been tested to date. This exploratory study aimed to translate, culturally adapt, and examine the psychometric properties of the MOSR for the Brazilian population (MOSR-BR). The process followed international guidelines, including translation, back-translation, expert committee review, and pre-testing. The final version was applied to a sample of 505 Brazilian adults. Exploratory factor analysis supported a unidimensional structure, explaining 47.6% of the variance. The MOSR-BR showed high internal consistency (α = .95), slightly higher than the original and Italian versions. Construct validity was evidenced by significant positive correlations between MOSR-BR and all subscales of the Death Transcendence Scale, as well as with the Religious and Existential Well-Being subscales of the Spiritual Well-Being Scale. The scale also discriminated between psychedelic substance users and non-users, with higher mystical orientation scores among occasional and frequent users. This exploratory study provides preliminary evidence supporting the value of further research on the MOSR-BR to address acknowledged limitations with the pilot study, including the cross-sectional design, non-causal inferences, recruitment method and participant self-selection, limited generalizability, absence of confirmatory factor analysis and test–retest reliability, and the need for larger and more diverse samples with longitudinal reliability assessment.
- Open Access
- 21 February 2026
- Published by Springer Nature in Current Addiction Reports
- Vol. 13 (1) , 13
Ayahuasca, DMT, and Mental Health: A Current Review of Scientific Studies
Purpose of Review: Summarizes preclinical and clinical evidence on ayahuasca—a traditional Amazonian brew combining N , N -Dimethyltryptamine (DMT) and β-carbolines—in treating depression, anxiety, post-traumatic stress disorder, substance use, eating, and personality disorders. Recent Findings: Preclinical work shows enhanced neuroplasticity, reduced inflammation, and oxidative stress. Human neuroimaging reveals decreased default mode network activity, increased functional connectivity and brain entropy, indicating a flexible neural state and modulation of pathways related to neuroplasticity, inflammation, and stress response. Summary: While promising, the evidence is mainly observational. Users report emotional breakthroughs, increased self-awareness, and mystical experiences tied to therapeutic outcomes. Ayahuasca appears to target core psychological and neurobiological processes across disorders but requires caution in psychotic or bipolar individuals and should be administered with support. Randomized trials are needed to confirm efficacy and safety. In structured, culturally sensitive settings, ayahuasca/DMT may offer a novel treatment and, by integrating indigenous wisdom with modern science, deepen our understanding of healing and consciousness.
- 21 February 2026
- Published by Springer Nature in Current Addiction Reports
- Vol. 13 (1) , 13
Open AccessAyahuasca, DMT, and Mental Health: A Current Review of Scientific Studies
Purpose of Review: Summarizes preclinical and clinical evidence on ayahuasca—a traditional Amazonian brew combining N , N -Dimethyltryptamine (DMT) and β-carbolines—in treating depression, anxiety, post-traumatic stress disorder, substance use, eating, and personality disorders. Recent Findings: Preclinical work shows enhanced neuroplasticity, reduced inflammation, and oxidative stress. Human neuroimaging reveals decreased default mode network activity, increased functional connectivity and brain entropy, indicating a flexible neural state and modulation of pathways related to neuroplasticity, inflammation, and stress response. Summary: While promising, the evidence is mainly observational. Users report emotional breakthroughs, increased self-awareness, and mystical experiences tied to therapeutic outcomes. Ayahuasca appears to target core psychological and neurobiological processes across disorders but requires caution in psychotic or bipolar individuals and should be administered with support. Randomized trials are needed to confirm efficacy and safety. In structured, culturally sensitive settings, ayahuasca/DMT may offer a novel treatment and, by integrating indigenous wisdom with modern science, deepen our understanding of healing and consciousness.
- 3 September 2025
- Published by SAGE Publications in Journal of Holistic Nursing
- Vol. 44 (4) , 390-401
Integrating Holistic Communication into Psychedelic-Assisted Therapies in Hospice and Palliative Care: An Approach Based on Peplau's Theory
Psychedelic-assisted therapy (PAT) has shown promising results in alleviating psychological and existential suffering among individuals with serious illnesses. In parallel, nursing offers a robust theoretical framework to guide therapeutic communication in this context. This article explores the application of Peplau's Theory of Interpersonal Relations (PTIR) as a foundation for holistic communication in PAT, particularly in hospice and palliative care. We examine how PTIR's core concepts (person, health, environment, and nursing) along with its articulation of therapeutic roles, phases of the nurse–patient relationship, and the concept of anxiety as a signal of unmet needs, can be integrated into PAT's preparation, dosing, and integration phases. Drawing on a fictional case study involving a patient with advanced cancer, we illustrate how nurses can use PTIR to support emotional processing, foster insight, and promote personal growth during psilocybin-assisted therapy. By aligning Peplau's theory with the emerging field of PAT, this article highlights nursing's vital contribution to the development of safe, ethical, and compassionate psychedelic care practices. The integration of PTIR into PAT provides a valuable model for holistic nursing, offering structured yet flexible guidance for therapeutic communication with patients facing the complex emotional, spiritual, and existential dimensions of life-limiting illness.
- 3 September 2025
- Published by SAGE Publications in Journal of Holistic Nursing
- Vol. 44 (4) , 390-401
Integrating Holistic Communication into Psychedelic-Assisted Therapies in Hospice and Palliative Care: An Approach Based on Peplau's Theory
Psychedelic-assisted therapy (PAT) has shown promising results in alleviating psychological and existential suffering among individuals with serious illnesses. In parallel, nursing offers a robust theoretical framework to guide therapeutic communication in this context. This article explores the application of Peplau's Theory of Interpersonal Relations (PTIR) as a foundation for holistic communication in PAT, particularly in hospice and palliative care. We examine how PTIR's core concepts (person, health, environment, and nursing) along with its articulation of therapeutic roles, phases of the nurse–patient relationship, and the concept of anxiety as a signal of unmet needs, can be integrated into PAT's preparation, dosing, and integration phases. Drawing on a fictional case study involving a patient with advanced cancer, we illustrate how nurses can use PTIR to support emotional processing, foster insight, and promote personal growth during psilocybin-assisted therapy. By aligning Peplau's theory with the emerging field of PAT, this article highlights nursing's vital contribution to the development of safe, ethical, and compassionate psychedelic care practices. The integration of PTIR into PAT provides a valuable model for holistic nursing, offering structured yet flexible guidance for therapeutic communication with patients facing the complex emotional, spiritual, and existential dimensions of life-limiting illness.
- 2 June 2025
- Published by Taylor & Francis in Progress in Palliative Care
- Vol. 33 (3) , 110-117
Validation of the Demoralization Scale for Brazilian cancer patients
- 2 June 2025
- Published by Taylor & Francis in Progress in Palliative Care
- Vol. 33 (3) , 110-117
Validation of the Demoralization Scale for Brazilian cancer patients
- 10 January 2025
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 58 (3) , 1-11
Death Anxiety Among Users and Non-Users of Psychedelics
This study is a survey-type, cross-sectional study conducted in Brazil (n = 517), with online data collection taking place from April to June 2022. The main objective of this study was to evaluate the death anxiety in users and non-users of psychedelics. To this end, we also assessed the validity and reliability of the Death Anxiety Scale in Brazil. The following instruments were used for data collection: a questionnaire for sociodemographic characterization, Death Anxiety Scale, Death Transcendence Scale, and Spiritual Well-Being Scale. Our main results indicated the following: 1) increased death anxiety is associated with never or almost never having used psychedelics; 2) death transcendence, especially creative and religious factors, was the only constant variable in all the explanatory models of the variation in death anxiety; 3) there is a negative relationship between death anxiety and mystical and religious factors of death transcendence. We interpret these results as follows: it's not psychedelics that reduce death anxiety - psychedelics can favor the experience of transcending death. And it's the possibility of transcending death, (idea of continuity beyond physical death, taking both spiritual and symbolic forms) that helps reduce death anxiety. These findings offer valuable insights into the role of psychedelics in human mortality perception.
- 10 January 2025
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 58 (3) , 1-11
Death Anxiety Among Users and Non-Users of Psychedelics
This study is a survey-type, cross-sectional study conducted in Brazil (n = 517), with online data collection taking place from April to June 2022. The main objective of this study was to evaluate the death anxiety in users and non-users of psychedelics. To this end, we also assessed the validity and reliability of the Death Anxiety Scale in Brazil. The following instruments were used for data collection: a questionnaire for sociodemographic characterization, Death Anxiety Scale, Death Transcendence Scale, and Spiritual Well-Being Scale. Our main results indicated the following: 1) increased death anxiety is associated with never or almost never having used psychedelics; 2) death transcendence, especially creative and religious factors, was the only constant variable in all the explanatory models of the variation in death anxiety; 3) there is a negative relationship between death anxiety and mystical and religious factors of death transcendence. We interpret these results as follows: it's not psychedelics that reduce death anxiety - psychedelics can favor the experience of transcending death. And it's the possibility of transcending death, (idea of continuity beyond physical death, taking both spiritual and symbolic forms) that helps reduce death anxiety. These findings offer valuable insights into the role of psychedelics in human mortality perception.
- 3 July 2024
- Published by Taylor & Francis in Progress in Palliative Care
- Vol. 32 (4) , 233-241
Contributions of the compassionate care approach to psychedelic-assisted therapies in hospice and palliative care
- 3 July 2024
- Published by Taylor & Francis in Progress in Palliative Care
- Vol. 32 (4) , 233-241
Contributions of the compassionate care approach to psychedelic-assisted therapies in hospice and palliative care
- 22 December 2023
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 80, 27-35
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial
- 22 December 2023
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 80, 27-35
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial
- 16 November 2023
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 57 (1) , 17-26
Spiritual Well-Being Among Users and Non-Users of Psychedelics: A Cross-Sectional Study
This study evaluated the psychometric properties of the Spiritual Well-Being Scale (SWBS) in a Brazilian sample. We analyzed spiritual well-being, defined as existential well-being (EWB) and religious well-being (RWB), among individuals with varying religious and spiritual experiences, both users and non-users of psychedelics. The online cross-sectional survey was conducted in Brazil, from April to June 2022. The psychometric analyses demonstrated reliability and validity based on the internal structure and the relationship with satisfactory external variables concerning the RWB and EWB factors of the SWBS. Validity evidence was shown for both factors (RWB, EWB) with adequate reliability ratings. However, the RWB factor, which was entirely replicated, demonstrated the best group differentiation and internal consistency. Although both factors showed validity, the RWB factor exhibited superior psychometric indices for validity, group discrimination, and reliability. Regarding psychedelics, the association with RWB and EWB demonstrates a U-shaped pattern, as participants who never use these substances typically exhibit higher RWB and EWB indices, succeeded by frequent users. This finding underscores the need for additional studies to further explore the intricate interplay between psychedelics and spiritual well-being.
- 16 November 2023
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 57 (1) , 17-26
Spiritual Well-Being Among Users and Non-Users of Psychedelics: A Cross-Sectional Study
This study evaluated the psychometric properties of the Spiritual Well-Being Scale (SWBS) in a Brazilian sample. We analyzed spiritual well-being, defined as existential well-being (EWB) and religious well-being (RWB), among individuals with varying religious and spiritual experiences, both users and non-users of psychedelics. The online cross-sectional survey was conducted in Brazil, from April to June 2022. The psychometric analyses demonstrated reliability and validity based on the internal structure and the relationship with satisfactory external variables concerning the RWB and EWB factors of the SWBS. Validity evidence was shown for both factors (RWB, EWB) with adequate reliability ratings. However, the RWB factor, which was entirely replicated, demonstrated the best group differentiation and internal consistency. Although both factors showed validity, the RWB factor exhibited superior psychometric indices for validity, group discrimination, and reliability. Regarding psychedelics, the association with RWB and EWB demonstrates a U-shaped pattern, as participants who never use these substances typically exhibit higher RWB and EWB indices, succeeded by frequent users. This finding underscores the need for additional studies to further explore the intricate interplay between psychedelics and spiritual well-being.